title: Optimisation of the assays for the measurement of clotting factor activity in the presence of rivaroxaban.
authors: Grigoris T
authors: GT
authors: Gerotziafas
authors: Hela
authors: H
authors: Baccouche
authors: Mouna
authors: M
authors: Sassi
authors: Vassiliki
authors: V
authors: Galea
authors: Mourad
authors: M
authors: Chaari
authors: Mohamed
authors: M
authors: Hatmi
authors: Meyer M
authors: MM
authors: Samama
authors: Ismail
authors: I
authors: Elalamy
mesh_terms: D000925:Anticoagulants / Q000494:pharmacology*; D015415:Biomarkers / Q000097:blood; D001777:Blood Coagulation / Q000187:drug effects*; D001779:Blood Coagulation Factors / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D006801:Humans; D009025:Morpholines / Q000494:pharmacology*; D010314:Partial Thromboplastin Time; D011237:Predictive Value of Tests; D011517:Prothrombin Time; D015203:Reproducibility of Results; D000069552:Rivaroxaban; D013876:Thiophenes / Q000494:pharmacology*; D013997:Time Factors
chemical_list: D000925:Anticoagulants; D015415:Biomarkers; D001779:Blood Coagulation Factors; D009025:Morpholines; D013876:Thiophenes; D000069552:Rivaroxaban